Today, as predicted by many commentators, the Supreme Court set aside the ruling by the Fed. Cir. that claims to isolated DNA sequences that are the BRCA 1 or 2 gene, or fragments thereof, are patentable subject matter. The Supreme Court ordered the Fed. Cir. to reconsider its 2-1 panel decision in view of its [...]
The post Supreme Court Remands In Myriad Appeal appeared first on Biotechnology Patent Law Blog | Patents4Life by Warren Woessner.